SCHEMBL30656309

SCHEMBL30656309

Cc1ncsc1COc1ccc2sc(C)c(C(=O)N[C@@H](CO)C(N)=O)c2c1

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SCN9A Q15858 2/20 0.32
KLKB1 P03952 1/20 0.32
KLK1 P06870 1/20 0.32
PPARG P37231 1/20 0.32
EDNRA P25101 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
LY96 Q9Y6Y9 1/20 0.30
MAPT P10636 1/20 0.30
PARP15 Q460N3 1/20 0.30
PARP10 Q53GL7 1/20 0.30
PPARD Q03181 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656033 1.00 NPC1 (0.33) NPC1RAB9ASCN9AKLKB1KLK1
SCHEMBL30656238 0.89 HPGDS (0.35) NPC1RAB9ASCN9AEDNRAL3MBTL1
SCHEMBL30656162 0.89 HPGDS (0.35) NPC1RAB9ASCN9AEDNRAL3MBTL1
SCHEMBL24485116 0.84 GAA (0.46) L3MBTL1MAPT
SCHEMBL29629946 0.84 GAA (0.46) L3MBTL1MAPT
SCHEMBL29630082 0.84 GAA (0.46) L3MBTL1MAPT
SCHEMBL29095412 0.84 GAA (0.46) L3MBTL1MAPT
SCHEMBL30656117 0.84 MEN1 (0.37) PPARGEDNRAL3MBTL1PPARD
SCHEMBL31350338 0.84 PARP10 (0.39) NPC1RAB9AEDNRAL3MBTL1PARP15
SCHEMBL30656028 0.83 L3MBTL1 (0.33) NPC1RAB9ASCN9AKLKB1EDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP claimed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO claimed
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed